companies / syncromune-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-13 json
| total_raised | 144,828,791144.8M | ○ |
|---|---|---|
| founded | null | |
| hq | Fort Lauderdale, FL | |
| industry | unknown | |
| stage | null |
Clinical-stage biopharmaceutical company developing SYNC-T, an in-situ immunotherapy platform for metastatic solid tumors.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-05-11 | Funding round | 144,828,791144.8M | null | ○ |
Cloudflare, WordPress 7.0, Yoast SEO 27.6, Yoast SEO Premium 27.5, Underscore.js 1.13.8, Kinsta, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, DoubleClick Floodlight, Cloudflare Bot Management, PHP
| fact | status | src |
|---|---|---|
| Funding round, $144.8M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $144.8M, 2026-05-11 → Funding round, $144.8M, 2026-05-11, ○ 2026-05-13 | latest_round | seed, $144.8M, 2026-05-11 → Funding round, $144.8M, 2026-05-11 | ○ 2026-05-13 |
Records begin 2026-09-24. all_changes